ERI Group
Daniel Simpson has worked as the Director of Regulatory Affairs at ERI Group (formerly Evergreen Research) since 2022. Before that, they were the Sr. Director of Quality and Regulatory Affairs at Corgenix Medical Corporation from 2008 to 2022.
Daniel Simpson graduated from Colorado State University in 1992 with a Bachelor of Science degree in Biology/Biological Sciences, General. In 2008, they obtained a certification in regulatory affairs through the Regulatory Affairs Certification Program.
This person is not in any teams
This person is not in any offices
ERI Group
We bring medical devices to life. ERI Group is a world-class, fully integrated contract design, development and manufacturing firm that turns great ideas into revolutionary medical devices. Ideas are the most powerful resource on Earth. They can be revolutionary and life-saving and can even alter the course of history. But ideas can also simply remain a thought, buried deep in someone’s mind, never to exist in the physical world. We believe good ideas should never go to waste, especially in healthcare and medicine, where new ideas will actually save lives. ERI Group offers our clients a world-class, multidisciplinary team that spans the entire process of bringing a medical device to market—from product design, development, quality, regulatory, and contract manufacturing. With 35 years of experience and deep technical expertise to handle the most complex projects, we connect the dots so our clients don’t have to.
Employees
51-200